Literature DB >> 18617680

Endogenous IL-11 signaling is essential in Th2- and IL-13-induced inflammation and mucus production.

Chun Geun Lee1, Dominik Hartl, Hiroshi Matsuura, Felicity M Dunlop, Pierre D Scotney, Louis J Fabri, Andrew D Nash, Ning-Yuan Chen, Chu-Yan Tang, Qingsheng Chen, Robert J Homer, Manuel Baca, Jack A Elias.   

Abstract

IL-11 and IL-11 receptor (R)alpha are induced by Th2 cytokines. However, the role(s) of endogenous IL-11 in antigen-induced Th2 inflammation has not been fully defined. We hypothesized that IL-11, signaling via IL-11Ralpha, plays an important role in aeroallergen-induced Th2 inflammation and mucus metaplasia. To test this hypothesis, we compared the responses induced by the aeroallergen ovalbumin (OVA) in wild-type (WT) and IL-11Ralpha-null mutant mice. We also generated and defined the effects of an antagonistic IL-11 mutein on pulmonary Th2 responses. Increased levels of IgE, eosinophilic tissue and bronchoalveolar lavage (BAL) inflammation, IL-13 production, and increased mucus production and secretion were noted in OVA-sensitized and -challenged WT mice. These responses were at least partially IL-11 dependent because each was decreased in mice with null mutations of IL-11Ralpha. Importantly, the administration of the IL-11 mutein to OVA-sensitized mice before aerosol antigen challenge also caused a significant decrease in OVA-induced inflammation, mucus responses, and IL-13 production. Intraperitoneal administration of the mutein to lung-specific IL-13-overexpressing transgenic mice also reduced BAL inflammation and airway mucus elaboration. These studies demonstrate that endogenous IL-11R signaling plays an important role in antigen-induced sensitization, eosinophilic inflammation, and airway mucus production. They also demonstrate that Th2 and IL-13 responses can be regulated by interventions that manipulate IL-11 signaling in the murine lung.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617680      PMCID: PMC2586049          DOI: 10.1165/rcmb.2008-0053OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  59 in total

Review 1.  New insights into the pathogenesis of asthma.

Authors:  Jack A Elias; Chun Geun Lee; Tao Zheng; Bing Ma; Robert J Homer; Zhou Zhu
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

2.  Combinations of cytokines promote survival of mice and limit acute radiation damage in concert with amelioration of vascular damage.

Authors:  Anne Van der Meeren; Marc-André Mouthon; Marie Vandamme; Claire Squiban; Jocelyne Aigueperse
Journal:  Radiat Res       Date:  2004-05       Impact factor: 2.841

Review 3.  TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells.

Authors:  Sharon M Wahl; Jennifer Swisher; Nancy McCartney-Francis; Wanjun Chen
Journal:  J Leukoc Biol       Date:  2004-02-13       Impact factor: 4.962

4.  Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop.

Authors:  Yin Chen; Philip Thai; Yu-Hua Zhao; Ye-Shih Ho; Mary M DeSouza; Reen Wu
Journal:  J Biol Chem       Date:  2003-03-06       Impact factor: 5.157

5.  Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism.

Authors:  T C T M van der Pouw Kraan; M Küçükaycan; A M Bakker; J M C Baggen; J S van der Zee; M A Dentener; E F M Wouters; C L Verweij
Journal:  Genes Immun       Date:  2002-11       Impact factor: 2.676

6.  Functional characterization of W147A: a high-affinity interleukin-11 antagonist.

Authors:  Nicholas Underhill-Day; Lisa A McGovern; Natalia Karpovich; Helen J Mardon; Victoria A Barton; John K Heath
Journal:  Endocrinology       Date:  2003-08       Impact factor: 4.736

7.  Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation.

Authors:  Zhou Zhu; Tao Zheng; Robert J Homer; Yoon-Keun Kim; Ning Yuan Chen; Lauren Cohn; Qutayba Hamid; Jack A Elias
Journal:  Science       Date:  2004-06-11       Impact factor: 47.728

Review 8.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

Authors:  Peter C Heinrich; Iris Behrmann; Serge Haan; Heike M Hermanns; Gerhard Müller-Newen; Fred Schaper
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

Review 9.  Biology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma.

Authors:  David B Corry; Farrah Kheradmand
Journal:  Am J Respir Med       Date:  2002

10.  Epithelial interleukin-11. Regulation by cytokines, respiratory syncytial virus, and retinoic acid.

Authors:  J A Elias; T Zheng; O Einarsson; M Landry; T Trow; N Rebert; J Panuska
Journal:  J Biol Chem       Date:  1994-09-02       Impact factor: 5.157

View more
  18 in total

1.  RIG-like helicase innate immunity inhibits vascular endothelial growth factor tissue responses via a type I IFN-dependent mechanism.

Authors:  Bing Ma; Charles S Dela Cruz; Dominik Hartl; Min-Jong Kang; Shervin Takyar; Robert J Homer; Chun Geun Lee; Jack A Elias
Journal:  Am J Respir Crit Care Med       Date:  2011-01-28       Impact factor: 21.405

2.  The histone demethylase KDM6B fine-tunes the host response to Streptococcus pneumoniae.

Authors:  Michael G Connor; Tiphaine M N Camarasa; Emma Patey; Orhan Rasid; Laura Barrio; Caroline M Weight; Daniel P Miller; Robert S Heyderman; Richard J Lamont; Jost Enninga; Melanie A Hamon
Journal:  Nat Microbiol       Date:  2020-12-21       Impact factor: 17.745

3.  Non-core region modulates interleukin-11 signaling activity: generation of agonist and antagonist variants.

Authors:  Saeko Yanaka; 中冴子 谷; Emiko Sano; 野恵海子 佐; Norio Naruse; 瀬紀男 成; Kin-Ichiro Miura; 浦謹一郎 三; Mutsumi Futatsumori-Sugai; ツ森ー菅井睦美 二; Jose M M Caaveiro; Kouhei Tsumoto; 本浩平 津
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

4.  Resistin deficiency in mice has no effect on pulmonary responses induced by acute ozone exposure.

Authors:  Shehla S Razvi; Jeremy B Richards; Farhan Malik; Kevin R Cromar; Roger E Price; Cynthia S Bell; Tingting Weng; Constance L Atkins; Chantal Y Spencer; Katherine J Cockerill; Amy L Alexander; Michael R Blackburn; Joseph L Alcorn; Ikram U Haque; Richard A Johnston
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

Review 5.  Mucus hypersecretion in asthma: causes and effects.

Authors:  Christopher M Evans; Kyubo Kim; Michael J Tuvim; Burton F Dickey
Journal:  Curr Opin Pulm Med       Date:  2009-01       Impact factor: 3.155

6.  IL11 antagonist inhibits uterine stromal differentiation, causing pregnancy failure in mice.

Authors:  Ellen Menkhorst; Lois Salamonsen; Lorraine Robb; Evdokia Dimitriadis
Journal:  Biol Reprod       Date:  2009-01-14       Impact factor: 4.285

7.  The structure of the extracellular domains of human interleukin 11α receptor reveals mechanisms of cytokine engagement.

Authors:  Riley D Metcalfe; Kaheina Aizel; Courtney O Zlatic; Paul M Nguyen; Craig J Morton; Daisy Sio-Seng Lio; Heung-Chin Cheng; Renwick C J Dobson; Michael W Parker; Paul R Gooley; Tracy L Putoczki; Michael D W Griffin
Journal:  J Biol Chem       Date:  2020-04-24       Impact factor: 5.157

8.  IL-17F-induced IL-11 release in bronchial epithelial cells via MSK1-CREB pathway.

Authors:  Mio Kawaguchi; Junichi Fujita; Fumio Kokubu; Shau-Ku Huang; Tetsuya Homma; Satoshi Matsukura; Mitsuru Adachi; Nobuyuki Hizawa
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-02-27       Impact factor: 5.464

9.  Interleukin-11 drives early lung inflammation during Mycobacterium tuberculosis infection in genetically susceptible mice.

Authors:  Marina A Kapina; Galina S Shepelkova; Vadim G Avdeenko; Anna N Guseva; Tatiana K Kondratieva; Vladimir V Evstifeev; Alexander S Apt
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

10.  Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.

Authors:  Petrus Jansen van Vuren; Caroline T Tiemessen; Janusz T Paweska
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.